ATLAS / Macro Radar / Reporting / XERS

Xeris Biopharma Holdings, Inc. (XERS) reporting calendar

Xeris Biopharma Holdings, Inc. files periodic reports with the SEC as XERS on Nasdaq. Atlas tracks 19 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
24 Jul 2026 – 21 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
19

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open XERS market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001867096-26-000030
10-K31 Dec 20252 Mar 202661 days0001867096-26-000016
10-Q30 Sep 20256 Nov 202537 days0001867096-25-000159
10-Q30 Jun 20257 Aug 202538 days0001867096-25-000136
10-Q31 Mar 20258 May 202538 days0001867096-25-000089
10-K31 Dec 20246 Mar 202565 days0001867096-25-000039
10-Q30 Sep 20248 Nov 202439 days0001867096-24-000187
10-Q30 Jun 20248 Aug 202439 days0001867096-24-000162
10-Q31 Mar 20249 May 202439 days0001867096-24-000065
10-K31 Dec 20236 Mar 202466 days0001867096-24-000031
10-Q30 Sep 20239 Nov 202340 days0001867096-23-000139
10-Q30 Jun 20238 Aug 202339 days0001867096-23-000114
10-Q31 Mar 20239 May 202339 days0001867096-23-000069
10-K31 Dec 20228 Mar 202367 days0001867096-23-000031
10-Q30 Sep 20229 Nov 202240 days0001867096-22-000127
10-Q30 Jun 202210 Aug 202241 days0001867096-22-000107
10-Q31 Mar 202211 May 202241 days0001867096-22-000063
10-K31 Dec 202111 Mar 202270 days0001867096-22-000040
10-Q30 Sep 202110 Nov 202141 days0001867096-21-000069

Source: SEC EDGAR company submissions for CIK 0001867096. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.